人工智能在早期食管与胃肿瘤影像诊断中的应用
本文综述人工智能(AI)在Barrett食管、食管鳞状细胞癌和早期胃癌等上消化道疾病影像诊断中的应用。深度学习与卷积神经网络可提高诊断准确性、减少不同临床环境下的诊断差异,并在早期癌检测、病灶表征、浸润深度预测和病灶边缘勾画方面显示潜力。但病灶形态细微、训练数据集多样性受限以及部分AI系统的「黑箱」性质,限制了其广泛推广。
要点
- 深度学习模型在早期癌检测、病灶表征、浸润深度预测和边缘勾画方面显示潜力。
- 病灶形态细微和训练数据集多样性受限可能制约AI模型的泛化能力。
- 部分AI系统的「黑箱」性质可能影响可解释性和临床医生信任。
核心结论
- AI有望在自动化实时内镜引导、个体化风险评估和优化活检决策方面取得实质进展,并影响上消化道疾病的早期诊断、预后及成本效益。
研究设计与样本
- 本文为综述,未报告系统检索范围。
主要发现
- 深度学习和卷积神经网络可提高诊断准确性并减少不同临床环境下的诊断差异。
- 深度学习模型在早期癌检测、病灶表征、浸润深度预测和病灶边缘勾画方面显示潜力。
- 训练数据集常来自专门中心且多样性受限,可能制约AI模型在不同临床环境下的泛化能力。
- 部分AI系统的「黑箱」性质可能妨碍可解释性和临床医生信任。
- 正在努力纳入多模态数据(如结合内镜与组织病理学影像)以增强模型稳健性和透明度。
临床怎么用
- 原文未据此给出推荐。
局限性
- 病灶形态细微和训练数据集多样性受限(常来自专门中心)可能制约AI模型在不同临床环境下的泛化能力。
- 部分AI系统的「黑箱」性质可能妨碍可解释性和临床医生信任。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Artificial intelligence (AI) holds the potential to transform the management of upper gastrointestinal (GI) conditions, such as Barrett's esophagus, esophageal squamous cell cancer, and early gastric cancer. Advancements in deep learning and convolutional neural networks offer improved diagnostic accuracy and reduced diagnostic variability across different clinical settings, particularly where human error or fatigue may impair diagnostic precision. Deep learning models have shown the potential to improve early cancer detection and lesion characterization, predict invasion depth, and delineate lesion margins with remarkable accuracy, all contributing to effective treatment planning. Several challenges, however, limit the broad application of AI in GI endoscopy, particularly in the upper GI tract. Subtle lesion morphology and restricted diversity in training datasets, which are often sourced from specialized centers, may constrain the generalizability of AI models in various clinical settings. Furthermore, the "black box" nature of some AI systems can impede explainability and clinician trust. To address these issues, efforts are underway to incorporate multimodal data, such as combining endoscopic and histopathologic imaging, to bolster model robustness and transparency. In the future, AI promises substantial advancements in automated real-time endoscopic guidance, personalized risk assessment, and optimized biopsy decision making. As it evolves, it would substantially impact not only early diagnosis and prognosis, but also the cost-effectiveness of managing upper GI diseases, ultimately leading to improved patient outcomes and more efficient health care delivery.
引用
- Ebigbo A, Messmann H, Lee SH, et al. Artificial Intelligence Applications in Image-Based Diagnosis of Early Esophageal and Gastric Neoplasms. Gastroenterology. 2025. PMID: 40043857. doi:10.1053/j.gastro.2025.01.253
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。